These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25096481)

  • 1. What is the need for comparative effectiveness studies in IBD?
    Flasar MH; Cross RK
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):851-4. PubMed ID: 25096481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in inflammatory bowel diseases in children.
    Michail S; Ramsy M; Soliman E
    Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups.
    Cheifetz AS; Melmed GY; Spiegel B; Talley J; Devlin SM; Raffals L; Irving PM; Jones J; Kaplan GG; Kozuch P; Sparrow M; Velayos F; Baidoo L; Bressler B; Siegel CA
    Inflamm Bowel Dis; 2012 Dec; 18(12):2294-300. PubMed ID: 22337359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing and managing inflammatory bowel disease.
    Assadsangabi A; Lobo AJ
    Practitioner; 2013; 257(1763):13-8, 2. PubMed ID: 24191430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomarkers in the diagnosis and therapy of inflammatory bowel diseases].
    Iijima H; Shinzaki S; Tsujii M; Takehara T
    Nihon Rinsho; 2012 May; 70(5):869-73. PubMed ID: 22620015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic inflammatory bowel diseases: state of the art].
    Maul J; Siegmund B
    Dtsch Med Wochenschr; 2014 Sep; 139(36):1771-5. PubMed ID: 25157865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future developments in diagnosis and treatment of inflammatory bowel disease.
    Schölmerich J
    Hepatogastroenterology; 2000; 47(31):101-14. PubMed ID: 10690590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving concepts on inflammatory bowel disease. Are we happy with the present nosology?
    Caprilli R; Viscido A
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):893-7. PubMed ID: 10670000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease in the pediatric patient.
    Ponsky T; Hindle A; Sandler A
    Surg Clin North Am; 2007 Jun; 87(3):643-58. PubMed ID: 17560417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease.
    Pearson C
    Nurs Times; 2004 Mar 2-8; 100(9):86-90. PubMed ID: 15038141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness research in inflammatory bowel disease: prospects and challenges.
    Feuerstein JD; Cheifetz AS; Siegel CA;
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):405-7. PubMed ID: 22928891
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new system of specialized gastroenterological care to patients with inflammatory bowel diseases in St. Petersburg].
    Baranovskiĭ AIu; Kondrashina ÉA; Segal' AM
    Ter Arkh; 2013; 85(2):17-20. PubMed ID: 23653933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inflammatory bowel disease: an overview].
    Herrlinger K
    Med Monatsschr Pharm; 2013 Nov; 36(11):402-8; quiz 409. PubMed ID: 24640117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guideline 'Diagnosis and treatment of inflammatory bowel disease in adults'. I. Diagnosis and treatment].
    van Bodegraven AA; van Everdingen JJ; Dijkstra G; de Jong DJ; Oldenburg B; Hommes DW;
    Ned Tijdschr Geneeskd; 2010; 154():A1899. PubMed ID: 21029496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When should we look for amebae in patients with inflammatory bowel disease?
    Korelitz BI
    J Clin Gastroenterol; 1989 Aug; 11(4):373-5. PubMed ID: 2760424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.